A detailed history of Rafferty Asset Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 226,800 shares of INSM stock, worth $16.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
226,800
Previous 112,214 102.11%
Holding current value
$16.7 Million
Previous $7.52 Million 120.22%
% of portfolio
0.06%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$62.0 - $79.01 $7.1 Million - $9.05 Million
114,586 Added 102.11%
226,800 $16.6 Million
Q2 2024

Aug 13, 2024

SELL
$22.0 - $69.71 $4.78 Million - $15.2 Million
-217,421 Reduced 65.96%
112,214 $7.52 Million
Q1 2024

May 13, 2024

BUY
$25.72 - $29.94 $219,854 - $255,927
8,548 Added 2.66%
329,635 $8.94 Million
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $1.11 Million - $1.51 Million
47,563 Added 17.39%
321,087 $9.95 Million
Q3 2023

Nov 13, 2023

SELL
$19.86 - $26.93 $1.94 Million - $2.63 Million
-97,602 Reduced 26.3%
273,524 $6.91 Million
Q2 2023

Aug 11, 2023

SELL
$16.44 - $21.1 $117,085 - $150,274
-7,122 Reduced 1.88%
371,126 $7.83 Million
Q1 2023

May 11, 2023

SELL
$16.26 - $21.73 $952,088 - $1.27 Million
-58,554 Reduced 13.41%
378,248 $6.45 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $2.68 Million - $3.65 Million
157,722 Added 56.51%
436,802 $8.73 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $2 Million - $2.71 Million
95,905 Added 52.36%
279,080 $6.01 Million
Q2 2022

Aug 12, 2022

SELL
$17.07 - $25.71 $995,607 - $1.5 Million
-58,325 Reduced 24.15%
183,175 $3.61 Million
Q1 2022

May 13, 2022

BUY
$20.42 - $28.13 $851,166 - $1.17 Million
41,683 Added 20.86%
241,500 $5.68 Million
Q4 2021

Feb 10, 2022

BUY
$25.89 - $33.45 $2.2 Million - $2.84 Million
85,043 Added 74.1%
199,817 $5.44 Million
Q3 2021

Nov 10, 2021

BUY
$22.46 - $29.47 $628,767 - $825,012
27,995 Added 32.26%
114,774 $3.16 Million
Q2 2021

Aug 10, 2021

BUY
$24.17 - $36.01 $38,647 - $57,579
1,599 Added 1.88%
86,779 $2.47 Million
Q1 2021

May 10, 2021

BUY
$32.28 - $44.3 $2 Million - $2.74 Million
61,809 Added 264.47%
85,180 $2.9 Million
Q4 2020

Feb 10, 2021

SELL
$31.45 - $40.54 $1.46 Million - $1.88 Million
-46,314 Reduced 66.46%
23,371 $778,000
Q3 2020

Nov 13, 2020

BUY
$26.0 - $34.5 $898,664 - $1.19 Million
34,564 Added 98.41%
69,685 $2.24 Million
Q2 2020

Aug 07, 2020

BUY
$14.11 - $29.42 $352,750 - $735,500
25,000 Added 247.01%
35,121 $967,000
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $1.04 Million - $2.58 Million
-75,961 Reduced 88.24%
10,121 $162,000
Q4 2019

Feb 10, 2020

SELL
$16.12 - $24.98 $2.29 Million - $3.55 Million
-142,149 Reduced 62.28%
86,082 $2.06 Million
Q3 2019

Nov 14, 2019

BUY
$15.49 - $25.78 $1.44 Million - $2.4 Million
92,953 Added 68.71%
228,231 $4.03 Million
Q2 2019

Aug 09, 2019

BUY
$23.0 - $32.19 $901,669 - $1.26 Million
39,203 Added 40.8%
135,278 $3.46 Million
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $1.34 Million - $2.99 Million
96,075 New
96,075 $2.79 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.